Levodopa prodrug mesylate, compositions thereof, and uses thereof

Details for Australian Patent Application No. 2006322051 (hide)

Owner XenoPort, Inc.

Inventors Nguyen, Mark Q.; Li, Jianhua; Dai, Xuedong; Zhou, Cindy X.; Xiang, Jia-Ning

Agent Davies Collison Cave

Pub. Number AU-B-2006322051

PCT Pub. Number WO2007/067495

Priority 60/741,876 05.12.05 US

Filing date 4 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 29 September 2011

International Classifications

C07C 229/36 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

A61K 31/24 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/067495 Priority application(s): WO2007/067495

29 September 2011 Application Accepted

  Published as AU-B-2006322051

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322057-Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexano ls

2006322050-Topical film compositions for delivery of actives